Alphamab Oncology
About:
Alphamab Oncology is a clinical-stage biopharmaceutical company dedicated to the discovery, development manufacturing and commercialization.
Website: http://www.alphamabonc.com
Top Investors: OrbiMed, Janchor Partners, PAG, Hudson Bay Capital Management, Heritage Provider Network
Description:
Alphamab Oncology is a clinical-stage biopharmaceutical company dedicated to the discovery, development manufacturing and commercialization of world-class innovative therapeutics for cancer treatment with multiple in-house proprietary platforms in bispecifics, protein engineering and antibody screening, Alphamab Oncology has built a robust pipeline in oncology/ immunology, and they are striving to develop next-generation or best-in-class medicines to address unmet medical needs globally.
$160M
$100M to $500M
Suzhou, Jiangsu, China
2009-01-01
hr(AT)alphamabonc.com
Xu Ting
251-500
2019-05-28
Public
© 2025 bioDAO.ai